Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential: Pharmacology, Clinical Effects, and Therapeutic Potential : ... Held on March 20-21, 1997, in Cannes, France - Hardcover

Hardcover

ISBN 10: 0792387295 ISBN 13: 9780792387299

Verlag: Springer, 1998

Inhaltsangabe

This volume is the proceedings of the William Harvey Research Conference held in Cannes, France, on the 20th and 21st March, 1997. It describes the present knowledge of the structures of the cyclooxygenase isoforms and the experimental and clinical effects of selective inhibitors of cyclooxygenase-2. The pathophysiological significance of the cyclooxygenase enzymes in tumorigenesis, programmed cell death, vascular disease and asthma is also covered.

Über diesen Titel

Über die Autorin bzw. den Autor

Sir John Vane is the Director General at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK.
Sir John Vane shared the Nobel Prize in Physiology or Medicine in 1982 for his discoveries of the mechanism of action of aspirin and of prostacyclin, as well as his work on other prostanoids. Jack Botting is Consultant at the William Harvey Research Institute, an independent charitable foundation within Queen Mary and Westfield College of the University of London, UK.

Details zur Ausgabe

• Verlag: Springer
• Erscheinungsdatum: 1998
• Sprache: Englisch
• ISBN 10: 0792387295
• ISBN 13: 9780792387299
• Einband: Gebundene Ausgabe
• Anzahl der Seiten: 150
• Herausgeber: Vane Sir John R., Botting Jack H.
• Kontakt zum Hersteller: Springer Nature Customer Service Center GmbH; ProductSafety@springernature.com; ; Europaplatz 3,69115 Heidelberg, Germany; Heidelberg; 69115; Deutschland